Brief: 4D Molecular Therapeutics Q2 Revenue USD 239 Thousand Vs. IBES Estimate USD 848.3 Thousand
09/08/2023 21:05
Aug 09 (Reuters) - 4D Molecular Therapeutics Q2 net income USD -29.616 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings